Host Membranes as Drivers of Virus Evolution

Viruses. 2023 Aug 31;15(9):1854. doi: 10.3390/v15091854.

Abstract

The molecular mechanisms controlling the adaptation of viruses to host cells are generally poorly documented. An essential issue to resolve is whether host membranes, and especially lipid rafts, which are usually considered passive gateways for many enveloped viruses, also encode informational guidelines that could determine virus evolution. Due to their enrichment in gangliosides which confer an electronegative surface potential, lipid rafts impose a first control level favoring the selection of viruses with enhanced cationic areas, as illustrated by SARS-CoV-2 variants. Ganglioside clusters attract viral particles in a dynamic electrostatic funnel, the more cationic viruses of a viral population winning the race. However, electrostatic forces account for only a small part of the energy of raft-virus interaction, which depends mainly on the ability of viruses to form a network of hydrogen bonds with raft gangliosides. This fine tuning of virus-ganglioside interactions, which is essential to stabilize the virus on the host membrane, generates a second level of selection pressure driven by a typical induced-fit mechanism. Gangliosides play an active role in this process, wrapping around the virus spikes through a dynamic quicksand-like mechanism. Viruses are thus in an endless race for access to lipid rafts, and they are bound to evolve perpetually, combining speed (electrostatic potential) and precision (fine tuning of amino acids) under the selective pressure of the immune system. Deciphering the host membrane guidelines controlling virus evolution mechanisms may open new avenues for the design of innovative antivirals.

Keywords: HIV-1; Monkeypox virus; SARS-CoV-2; cholesterol; electrostatic potential; evolution; gangliosides; hydrogen bond; lipid rafts; mutations.

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Gangliosides
  • Humans
  • SARS-CoV-2 / genetics

Substances

  • Antiviral Agents
  • Gangliosides

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

This research received no external funding.